On Tuesday, 27 February 2018, the representative of the Republic of South Africa delivered the following statement at the World Trade Organization’s TRIPS Council; South Africa delivered this statement under the agenda item on IP and the Public Interest: Regulatory… Continue Reading →
December 12 to December 15, 2016 WIPO’s Page on the Meeting SCP 25: Opening statement of Knowledge Ecology International SCP25: Statement of Asia Pacific Group on Patents and Health SCP25: South Africa’s Experience Related to the Topic of Access to… Continue Reading →
More on 1498 here: https://www.keionline.org/cl/28usc1498 There is a discussion of compensation under 28 USC §1498 in Remuneration Guidelines for Non-Voluntary Use of a Patent on Medical Technologies. UNDP and World Health Organization. 2005 (pages 18-21 in the UNDP edition, and… Continue Reading →
December 11 to December 15, 2017 WIPO’s Page for the Meeting SCP27: WIPO patent committee agrees to future work on patent oppositions, exceptions and limitations, and patents and health SCP27: South Africa urges WIPO to invite UNHLP Co-Chairs to present… Continue Reading →
KEI page on the World Trade Organization’s (WTO) Trade Policy Reviews All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes place in the “Trade Policy Review Body which is actually… Continue Reading →
Representative Ro Khanna (D-CA-17) was joined by 17 other members of Congress in calling upon Department of Health and Human Services Secretary Alex Azar to issue a compulsory license on patents for medications to treat hepatitis C, by exercising 28… Continue Reading →
Read first: Statutory authority for compulsory licenses on patents in the United States KEI Workshop: Feb 24, 2017 – U.S. History, Experiences, and Prospects of Compulsory Licensing of Medical Patents. There is a Video of the event here here. Non-voluntary… Continue Reading →
new: we have added a database of more than 1,000 federal court cases that cite 28 USC 1498 here: http://drugdatabase.info/28usc1498/ The United States government can use any patented invention, copyright, or protection of plant variety, original design or semiconductor design,… Continue Reading →
The October 2017 meeting of the WTO TRIPS Council witnessed heated discussions on compulsory licensing within the context of IP and the Public Interest. As reported earlier by Knowledge Ecology International, on 31 May 2017, Brazil, China, Fiji, India, and… Continue Reading →
https://www.keionline.org/?s=injunction Selected U.S. Patent Injunction Cases 2017. Wisconsin Alumni Research Foundation v. APPLE, INC., Dist. Court, WD Wisconsin 2017 At the end of the day, the court concludes that WARF has not met its burden of demonstrating irreparable harm, and… Continue Reading →